THE CENTER ON
For decades, Indian pharmaceutical companies have manufactured and supplied low-cost generic medicines, such as the life-saving antiretroviral drugs prescribed to AIDS patients. But recent changes in India’s patent law could soon make these drugs unaffordable in many parts of the world.
Watch “Patients vs. Patents” on the website of HDNet’s Dan Rather Reports for the Center’s investigation into how global pharmaceutical giants, with the help of the U.S. government, have changed India’s patent law for their own benefit.